Paresh Patel - Aug 23, 2022 Form 4 Insider Report for HCI Group, Inc. (HCI)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Andrew L. Graham as Attorney-in-fact for Paresh Patel
Stock symbol
HCI
Transactions as of
Aug 23, 2022
Transactions value $
$51,080
Form type
4
Date filed
8/24/2022, 04:01 PM
Previous filing
Apr 5, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCI Common stock Purchase $51.1K +1K +2.74% $51.08 37.5K Aug 23, 2022 IRA
holding HCI Common Stock 273K Aug 23, 2022 Direct
holding HCI Common stock 447K Aug 23, 2022 Direct F1
holding HCI Common Stock 10K Aug 23, 2022 Direct F2
holding HCI Common Stock 20K Aug 23, 2022 Direct F3
holding HCI Common Stock 30K Aug 23, 2022 Direct F4
holding HCI Common Stock 10K Aug 23, 2022 Direct F5
holding HCI Common Stock 10K Aug 23, 2022 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCI Stock Option (Right to Buy) 110K Aug 23, 2022 Common 110K $40.00 Direct F7, F8
holding HCI Stock Option (Right to Buy) 110K Aug 23, 2022 Common 110K $40.00 Direct F7, F9
holding HCI Stock Option (Right to Buy) 110K Aug 23, 2022 Common 110K $53.00 Direct F7, F10
holding HCI Stock Option (Right to Buy) 110K Aug 23, 2022 Common 110K $48.00 Direct F7, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held jointly with spouse.
F2 Restricted stock grant of 40,000 shares effective February 8, 2018: Restrictions on 10,000 shares have lapsed. Restrictions on the remaining 30,000 shares will lapse in 10,000 amounts on each of February 8, 2020, February 8, 2021, and February 8, 2022. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated February 8, 2018.
F3 Restricted stock grant of 40,000 shares effective January 15, 2019: Restrictions on 10,000 shares have lapsed. Restrictions on the remaining 30,000 shares will lapse in 10,000 amounts on each of January 15, 2021, January 15, 2022, and January 15, 2023. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated January 15, 2019.
F4 Restricted stock grant of 40,000 shares effective January 16, 2020: Restrictions on 10,000 shares will lapse on each of January 16, 2021, January 16, 2022, January 16, 2023, and January 16, 2024. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated January 16, 2020.
F5 Restricted stock grant of 10,000 shares effective 2/26/2021: Restricted shares will vest on October 5, 2022, which is the first anniversary of the date on which the company stock value first equaled or exceeded $105 for 30 consecutive trading days on the applicable exchange. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.
F6 Restricted stock grant of 10,000 shares effective 2/26/2021: Restricted shares will vest, if ever, on the first anniversary of the date on which the company stock value first equals or exceeds $140 for 30 consecutive trading days on the applicable exchange. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.
F7 The options were granted pursuant to the HCI Group, Inc. 2012 Omnibus Incentive Plan.
F8 The options were granted on January 7, 2017 at an exercise price of $40.00 per share, in excess of the $39.71 market value. Commencing on January 7, 2018 and continuing on the same day of each calendar year thereafter through and including January 7, 2021, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including January 7, 2027.
F9 The options were granted on February 8, 2018 at an exercise price of $40.00 per share, in excess of the $34.92 market value. Commencing on February 8, 2019 and continuing on the same day of each calendar year thereafter through and including February 8, 2022, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including February 8, 2028.
F10 The options were granted on January 15, 2019 at an exercise price of $53.00 per share, in excess of the $47.94 market value. Commencing on January 15, 2020 and continuing on the same day of each calendar year thereafter through and including January 15, 2023, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including January 15, 2029.
F11 The options were granted on January 16, 2020 at an exercise price of $48.00 per share, in excess of the $45.97 market value. Commencing on January 16, 2021 and continuing on the same day of each calendar year thereafter through and including January 16, 2024, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including January 16, 2030.